Ge Xin, Loh Horace H, Law Ping-Yee
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, 55455, USA.
Mol Pharmacol. 2009 Jun;75(6):1307-16. doi: 10.1124/mol.108.054064. Epub 2009 Mar 16.
The trafficking of the mu-opioid receptor (MOR), a member of the rhodopsin G protein-coupled receptor (GPCR) family, can be regulated by interaction with multiple cellular proteins. To determine the proteins involved in receptor trafficking, using the targeted proteomic approach and mass spectrometry analysis, we have identified that Ribophorin I (RPNI), a component of the oligosaccharide transferase complex, could directly interact with MOR. RPNI can be shown to participate in MOR export by the intracellular retention of the receptor after small interfering RNA knockdown of endogenous RPNI. Overexpression of RPNI rescued the surface expression of the MOR 344KFCTR348 deletion mutant independent of calnexin. Furthermore, RPNI regulation of MOR trafficking is dependent on the glycosylation state of the receptor, as reflected by the inability of overexpression of RPNI to affect the trafficking of the N-glycosylation-deficient mutants, or GPCRs that have minimal glycosylation sites. Hence, this novel RPNI chaperone activity is a consequence of N-glycosylation-dependent direct interaction with MOR.
μ-阿片受体(MOR)是视紫红质G蛋白偶联受体(GPCR)家族的成员之一,其转运可通过与多种细胞蛋白相互作用来调节。为了确定参与受体转运的蛋白,我们采用靶向蛋白质组学方法和质谱分析,鉴定出寡糖转移酶复合物的一个组分核糖体结合蛋白I(RPNI)可直接与MOR相互作用。通过对内源性RPNI进行小干扰RNA敲低后受体的细胞内滞留,可以证明RPNI参与MOR的输出。RPNI的过表达挽救了MOR 344KFCTR348缺失突变体的表面表达,且不依赖于钙连蛋白。此外,RPNI对MOR转运的调节取决于受体的糖基化状态,这表现为RPNI过表达无法影响N-糖基化缺陷突变体或糖基化位点极少的GPCR的转运。因此,这种新的RPNI伴侣活性是与MOR进行N-糖基化依赖性直接相互作用的结果。